Literature DB >> 12184518

High-fiber diet supplementation in patients with irritable bowel syndrome (IBS): a multicenter, randomized, open trial comparison between wheat bran diet and partially hydrolyzed guar gum (PHGG).

G C Parisi1, M Zilli, M P Miani, M Carrara, E Bottona, G Verdianelli, G Battaglia, S Desideri, A Faedo, C Marzolino, A Tonon, M Ermani, G Leandro.   

Abstract

High-fiber diet supplementation is commonly used in IBS, although it poses several management problems. Partially hydrolyzed guar gum (PHGG) has shown beneficial effects in animal and human studies, but its potential role in IBS symptom relief has not been evaluated yet. We investigated PHGG in IBS patients and compared it to a wheat bran diet. Abdominal pain, bowel habits, and subjective overall rating were longitudinally evaluated in 188 adult IBS patients (139 women and 49 men) for 12 weeks. Patients were classified as having diarrhea-predominant, constipation-predominant, or changeable bowel habits and were randomly assigned to groups receiving fiber (30 g/day of wheat bran) or PHGG (5 g/day). After four weeks, patients were allowed to switch group, depending on their subjective evaluation of their symptoms. Significantly more patients switched from fiber to PHGG (49.9%) than from PHGG to fiber (10.9%) at four weeks. Per protocol analysis showed that both fiber and PHGG were effective in improving pain and bowel habits, but no difference was found between the two groups. Conversely, intention-to-treat analysis showed a significantly greater success in the PHGG group (60%) than in the fiber group (40%). Moreover, significantly more patients in the PHGG group reported a greater subjective improvement than those in the Fiber group. In conclusion, improvements in core IBS symptoms (abdominal pain and bowel habits) were observed with both bran and PHGG, but the latter was better tolerated and preferred by patients, revealing a higher probability of success than bran and a lower probability of patients abandoning the prescribed regimen, suggesting that it can increase the benefits deriving from fiber intake in IBS, making it a valid option to consider for high-fiber diet supplementation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12184518     DOI: 10.1023/a:1016419906546

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  35 in total

1.  American Gastroenterological Association medical position statement: irritable bowel syndrome.

Authors: 
Journal:  Gastroenterology       Date:  1997-06       Impact factor: 22.682

2.  Is bran efficacious in irritable bowel syndrome? A double blind placebo controlled crossover study.

Authors:  M R Lucey; M L Clark; J Lowndes; A M Dawson
Journal:  Gut       Date:  1987-02       Impact factor: 23.059

3.  Adequate relief as an endpoint in clinical trials in irritable bowel syndrome.

Authors:  A W Mangel; B A Hahn; A T Heath; A R Northcutt; S Kong; G E Dukes; D McSorley
Journal:  J Int Med Res       Date:  1998 Mar-Apr       Impact factor: 1.671

4.  Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters.

Authors:  K W Heaton; L J O'Donnell; F E Braddon; R A Mountford; A O Hughes; P J Cripps
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

Review 5.  Irritable bowel syndrome: definition, diagnosis and epidemiology.

Authors:  N J Talley
Journal:  Baillieres Best Pract Res Clin Gastroenterol       Date:  1999-10

6.  Influence of intact and partially hydrolysed guar gum on iron utilization in rats fed on iron-deficient diets.

Authors:  H Takahashi; S I Yang; Y Ueda; M Kim; T Yamamoto
Journal:  Comp Biochem Physiol Physiol       Date:  1994-09

7.  Effect of dietary fiber on symptoms and rectosigmoid motility in patients with irritable bowel syndrome. A controlled, crossover study.

Authors:  I J Cook; E J Irvine; D Campbell; S Shannon; S N Reddy; S M Collins
Journal:  Gastroenterology       Date:  1990-01       Impact factor: 22.682

Review 8.  Bran: may irritate irritable bowel.

Authors:  M J Lewis; P J Whorwell
Journal:  Nutrition       Date:  1998-05       Impact factor: 4.008

9.  Effect of wheat bran on weight of stool and gastrointestinal transit time: a meta analysis.

Authors:  S A Müller-Lissner
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-27

10.  Bran supplementation in the treatment of irritable bowel syndrome.

Authors:  J Snook; H A Shepherd
Journal:  Aliment Pharmacol Ther       Date:  1994-10       Impact factor: 8.171

View more
  16 in total

1.  Treatment effects of partially hydrolyzed guar gum on symptoms and quality of life of patients with irritable bowel syndrome. A multicenter randomized open trial.

Authors:  Giancarlo Parisi; Enrico Bottona; Maurizio Carrara; Fabrizio Cardin; Alessandra Faedo; Dario Goldin; Marco Marino; Maurizio Pantalena; Gianni Tafner; Giorgio Verdianelli; Maurizio Zilli; Gioacchino Leandro
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

2.  Application of dietary fiber in clinical enteral nutrition: a meta-analysis of randomized controlled trials.

Authors:  Gang Yang; Xiao-Ting Wu; Yong Zhou; Ying-Li Wang
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

3.  Development of gluten-free muffins utilizing squash seed dietary fiber.

Authors:  María I Palacio; Analía I Etcheverría; Guillermo D Manrique
Journal:  J Food Sci Technol       Date:  2018-05-21       Impact factor: 2.701

4.  Partially hydrolyzed guar gum accelerates colonic transit time and improves symptoms in adults with chronic constipation.

Authors:  Dimitrios Polymeros; Iosif Beintaris; Asimina Gaglia; George Karamanolis; Ioannis S Papanikolaou; George Dimitriadis; Konstantinos Triantafyllou
Journal:  Dig Dis Sci       Date:  2014-04-08       Impact factor: 3.199

5.  Partially hydrolyzed guar gum in pediatric functional abdominal pain.

Authors:  Claudio Romano; Donatella Comito; Annalisa Famiani; Sabrina Calamarà; Italia Loddo
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

Review 6.  Evaluation of drug treatment in irritable bowel syndrome.

Authors:  Nicholas J Talley
Journal:  Br J Clin Pharmacol       Date:  2003-10       Impact factor: 4.335

7.  Structural basis of exo-β-mannanase activity in the GH2 family.

Authors:  Mariane Noronha Domingues; Flavio Henrique Moreira Souza; Plínio Salmazo Vieira; Mariana Abrahão Bueno de Morais; Letícia Maria Zanphorlin; Camila Ramos Dos Santos; Renan Augusto Siqueira Pirolla; Rodrigo Vargas Honorato; Paulo Sergio Lopes de Oliveira; Fabio Cesar Gozzo; Mário Tyago Murakami
Journal:  J Biol Chem       Date:  2018-07-11       Impact factor: 5.157

Review 8.  Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.

Authors:  Lisa Ruepert; A Otto Quartero; Niek J de Wit; Geert J van der Heijden; Gregory Rubin; Jean Wm Muris
Journal:  Cochrane Database Syst Rev       Date:  2011-08-10

9.  Integrative medicine and human health - the role of pre-, pro- and synbiotics.

Authors:  Stig Bengmark
Journal:  Clin Transl Med       Date:  2012-05-28

Review 10.  Fiber and prebiotics: mechanisms and health benefits.

Authors:  Joanne Slavin
Journal:  Nutrients       Date:  2013-04-22       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.